Latest Deep vein thrombosis Stories
Seven-fold lower incidence of VTE in patients treated with ISIS-FXI Rx compared with enoxaparin CARLSBAD, Calif., Dec. 7, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc.
SAN FRANCISCO, Dec.
Designation Helps Improve Patient Access to Kcentra in the Inpatient Hospital Setting KING OF PRUSSIA, Pa., Dec.
PLANO, Texas, Nov. 19, 2014 /PRNewswire/ -- Argon Medical Devices, Inc.
- Retrospective analysis of more than 38,000 patients shows PRADAXA is associated with lower rates of stroke and major bleeding compared to warfarin RIDGEFIELD, Conn., Nov.
Findings presented at American Heart Association's Scientific Sessions add to growing body of data supporting safety and effectiveness of PRADAXA RIDGEFIELD, Conn., Nov.
The Firm is representing individuals in Xarelto lawsuits that allege use of the blood-thinning medication caused serious complications, including uncontrollable internal bleeding. New
The Firm is evaluating Xarelto lawsuits on behalf of patients who experienced uncontrollable internal bleeding, strokes, deep vein thrombosis, pulmonary embolism, or other complications allegedly
- RE-VERSE AD(TM) is being conducted in more than 35 countries with aim to enroll 250 patients RIDGEFIELD, Conn., Nov. 10, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
Xarelto Page Launched to Monitor Lawsuits Being Filed on Behalf of Patients Who Allege the Blood Thinner Causes Severe Internal Bleeding and Uncontrollable Bleeding New
- The governor of a province or people.